Clinical trial Recruiting at 1 site Interventional Ages 30 to 60

High-intensity laser versus standard physical therapy for knee osteoarthritis

Official title: Rehabilitation of Knee Osteoarthritis by High Intensity Laser Therapy vs Classical Modalities

Run by Erbil Polytechnic University · NCT07551245 · Data updated 2026-11-12

This trial will try high-intensity laser therapy plus exercises against standard physical therapy plus exercises in adults aged 40–75 with mild-to-moderate knee osteoarthritis to see which reduces pain and improves knee function.

Quick facts

Study typeInterventional
Ages30 Years to 60 Years
SexAll
Enrollment100 (estimated)
SponsorErbil Polytechnic University
Academic / other
Locations1 site (Erbil, Erbil Governorate)
StatusRecruiting
StartedApril 20, 2026
Main results expectedJanuary 15, 2027
Study endsJanuary 20, 2027
Registry record updatedApril 24, 2026
Trial IDNCT07551245 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 40–75 years old with clinical and radiographic knee osteoarthritis (Kellgren-Lawrence grades 1–3) who can attend treatment sessions and provide informed consent are ideal candidates.

Probably not a fit

People with severe (Kellgren-Lawrence grade 4) knee OA, recent knee surgery, active infection, photosensitivity, epilepsy, active malignancy, or other contraindications to laser therapy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized comparative trial enrolling 100 adults with ACR-confirmed knee osteoarthritis at rehabilitation centers in Erbil, Iraq. Participants will be randomly assigned to receive either high-intensity laser therapy combined with therapeutic exercise or conventional physical therapy modalities combined with the same exercise program. The primary outcome is pain intensity at four weeks measured by WOMAC/VAS, with additional assessments of joint function, MRI structural changes, and laboratory markers of inflammation and cartilage health over follow-up. Safety and adverse events related to the interventions will also be recorded.

Why it matters

Potential benefit: If successful, high-intensity laser therapy could provide faster pain relief and better knee function than conventional modalities, potentially reducing disability and reliance on medications.

How similar studies have gone: Low-level laser therapy has produced mixed results in knee OA and high-intensity laser therapy is less studied but has shown promising results in small, limited trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of Knee Osteoarthritis: Patients must have a clinical and radiographic diagnosis of knee OA according to the American College of Rheumatology (ACR) criteria, including evidence of joint space narrowing, osteophyte formation, and other degenerative changes observed on X-rays or MRI.

Age: Adults aged between 40 and 75 years. Willingness to Participate: Participants must provide informed consent and be willing to adhere to the study protocol, including attending all treatment sessions and follow-up assessments.

Kellgren-Lawrence Grade: Patients with knee OA grades 1-3 (mild to moderate OA).

Exclusion Criteria:

* Contraindications to Laser Therapy:

Active malignancy History of epilepsy Photosensitivity disorders Active infection in the treatment area

Surgical History:

Patients who have undergone knee surgery within the past 6 months Scheduled surgery during the study period

Advanced Disease:

Kellgren-Lawrence Grade 4 (severe OA) where surgical intervention is indicated

Pregnancy or Lactation:

Pregnant or lactating women

Severe Comorbidities:

Uncontrolled diabetes Severe cardiovascular disease Neurological disorders that might interfere with participation or affect treatment outcomes

Where it's running

  • Aylan Center
    Erbil, Erbil Governorate, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.